UroGen Pharma Ltd.
URGN
$47.11
$0.801.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -23.03% | 16.45% | -5.18% | -19.06% | -19.88% |
| Total Receivables | 60.18% | 67.50% | 67.90% | 0.27% | 0.06% |
| Inventory | 17.53% | 27.07% | 97.39% | 17.02% | -6.09% |
| Prepaid Expenses | -34.58% | 33.11% | 21.04% | 0.56% | -7.15% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.15% | -1.70% | 0.22% | 24.49% | 0.56% |
| Total Current Assets | -0.86% | 27.65% | 10.37% | -14.39% | -17.00% |
|
|
|||||
| Total Current Assets | -0.86% | 27.65% | 10.37% | -14.39% | -17.00% |
| Net Property, Plant & Equipment | -3.87% | -5.91% | -0.99% | 47.20% | 15.97% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.54% | 43.69% | -23.04% | 609.20% | 78.79% |
| Total Assets | -0.43% | 26.56% | 8.33% | -11.34% | -15.71% |
|
|
|||||
| Total Accounts Payable | -10.09% | 41.79% | 18.08% | -24.22% | -6.89% |
| Total Accrued Expenses | 31.29% | -3.86% | 7.73% | -7.01% | 27.82% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.34% | 9.17% | 10.52% | 2.58% | 9.48% |
| Total Finance Division Other Current Liabilities | 115.55% | 3.09% | 1.81% | -0.68% | 2.88% |
| Total Other Current Liabilities | 115.55% | 3.09% | 1.81% | -0.68% | 2.88% |
| Total Current Liabilities | 22.28% | 9.08% | 9.88% | -11.16% | 13.21% |
|
|
|||||
| Total Current Liabilities | 22.28% | 9.08% | 9.88% | -11.16% | 13.21% |
| Long-Term Debt | -0.42% | 55.09% | 0.08% | -0.32% | 0.33% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.16% | -7.76% | -1.91% | 82.86% | 20.13% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -2.34% | 0.73% | 1.02% | 0.96% | 1.18% |
| Total Liabilities | 1.86% | 23.54% | 1.82% | -0.54% | 2.73% |
|
|
|||||
| Common Stock & APIC | 0.72% | 0.56% | 4.44% | 1.40% | 0.38% |
| Retained Earnings | -1.46% | -2.46% | -2.82% | -3.71% | -5.87% |
| Treasury Stock & Other | -125.00% | -57.89% | -17.39% | 283.33% | -57.14% |
| Total Common Equity | -6.55% | -17.80% | 8.61% | -23.59% | -100.99% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.55% | -17.80% | 8.61% | -23.59% | -100.99% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.55% | -17.80% | 8.61% | -23.59% | -100.99% |
|
|
|||||